COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 (CGEN)

Historical Holders from Q1 2014 to Q3 2025

Symbol
CGEN on Nasdaq
Type / Class
Equity / Ordinary Shares, par value NIS 0.01
Shares outstanding
89,326,990
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
12,448,286
Holdings value
$18,304,014
% of all portfolios
0%
Number of holders
67
Number of buys
20
Number of sells
-28
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 (CGEN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BRISTOL MYERS SQUIBB CO 2.06% $2,723,401 1,840,136 BRISTOL MYERS SQUIBB CO 31 Dec 2024

Institutional Holders of COMPUGEN LTD - Ordinary Shares, par value NIS 0.01 (CGEN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 12,448,286 $18,304,014 -$4,183,367 $1.47 67
2025 Q2 15,139,685 $26,790,623 +$183,382 $1.78 68
2025 Q1 15,090,164 $22,053,607 +$4,245,948 $1.46 71
2024 Q4 12,186,219 $18,646,397 -$28,651 $1.53 68
2024 Q3 11,987,352 $21,696,784 -$567,864 $1.81 64
2024 Q2 12,305,636 $20,720,522 -$1,505,161 $1.68 65
2024 Q1 12,748,693 $32,862,738 +$5,173,490 $2.58 71
2023 Q4 10,826,281 $21,446,061 -$868,253 $1.98 71
2023 Q3 12,534,496 $11,648,799 +$912,972 $0.93 61
2023 Q2 11,454,619 $13,055,912 +$792,401 $1.14 63
2023 Q1 10,938,583 $7,680,803 -$3,735,798 $0.702 64
2022 Q4 16,116,742 $11,522,279 -$3,810,001 $0.7157 66
2022 Q3 21,939,171 $14,470,393 -$27,601,323 $0.6572 71
2022 Q2 38,292,142 $70,071,925 -$7,799,772 $1.85 81
2022 Q1 41,974,425 $135,261,109 +$24,332,823 $3.22 103
2021 Q4 34,045,006 $147,109,241 -$8,267,484 $4.3 110
2021 Q3 35,282,290 $210,636,141 -$11,592,998 $5.97 103
2021 Q2 36,945,470 $305,730,622 -$26,358,920 $8.28 105
2021 Q1 40,064,043 $344,003,423 +$10,868,134 $8.59 105
2020 Q4 38,405,443 $465,291,847 -$89,128,926 $12.11 99
2020 Q3 43,347,749 $704,457,313 +$67,071,360 $16.25 107
2020 Q2 39,307,332 $590,159,903 +$135,675,063 $15.02 90
2020 Q1 31,865,087 $231,287,000 +$63,846,487 $7.26 65
2019 Q4 23,097,585 $137,648,000 +$8,576,336 $5.96 54
2019 Q3 21,656,187 $91,586,000 +$26,415,199 $4.23 42
2019 Q2 15,375,371 $59,066,000 +$5,570,229 $3.84 41
2019 Q1 13,973,276 $57,854,000 +$9,460,253 $4.14 39
2018 Q4 11,728,077 $25,448,000 +$522,008 $2.17 36
2018 Q3 11,120,308 $42,813,000 +$2,424,453 $3.85 34
2018 Q2 10,631,974 $35,083,000 -$4,178,184 $3.3 35
2018 Q1 10,870,849 $48,282,000 +$3,972,904 $4.45 36
2017 Q4 10,576,715 $26,442,000 +$3,741,499 $2.5 37
2017 Q3 8,913,963 $33,869,000 -$2,319,225 $3.8 34
2017 Q2 8,943,614 $33,994,000 -$1,142,087 $3.8 36
2017 Q1 9,200,354 $39,559,000 +$3,929,235 $4.3 39
2016 Q4 8,937,685 $45,579,425 +$227,680 $5.1 49
2016 Q3 8,658,716 $54,510,000 +$9,580,174 $6.3 46
2016 Q2 7,123,813 $46,158,000 +$4,710,745 $6.48 41
2016 Q1 6,412,273 $35,778,820 +$1,301,148 $5.58 41
2015 Q4 6,163,378 $39,350,000 +$10,613,523 $6.39 49
2015 Q3 4,502,769 $23,270,760 -$1,241,474 $5.17 41
2015 Q2 4,469,489 $31,003,246 -$1,063,840 $6.94 43
2015 Q1 4,083,380 $32,603,303 +$1,085,507 $7.05 42
2014 Q4 3,439,266 $36,782,604 -$13,047,015 $8.33 39
2014 Q3 2,857,139 $52,681,832 +$30,108,934 $8.57 37
2014 Q2 2,631,385 $23,650,509 -$11,356,232 $8.99 34
2014 Q1 3,729,722 $39,199,863 +$6,976,688 $10.51 42